Treatment with Brusatol inhibits oncogenic transcription factors NRF2 and TAZ, reducing glioma stem cells survival

Autor:	Ricardo Gargini, Marta Pajares, Diego Lastra, Antonio Cuadrado, Natalia Robledinos-Antón, C Centro de Biología Molecular 'Severo Ochoa' Csic-Uam, Maribel Escoll
Rok vydání:	2018
Předmět:	business.industry Glioma Cancer research Medicine Stem cell business medicine.disease Drug toxicity Transcription factor Pharmacogenetics
Zdroj:	IBJ Plus.
ISSN:	2531-0151
Popis:	Resumen del trabajo presentado al 5th Symposium on Biomedical Research: "Advances and Perspectives In Pharmacology, Drug Toxicity and Pharmacogenetics", celebrado en Madrid del 15 al 16 de marzo de 2018.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::e119fc03cf8b673d1b91bd85556b7a3b https://doi.org/10.24217/2531-0151.18v1s1.00030 Zobrazit plný text záznamu